391.5 USD
6.05
1.52%
Last update Dec 15, 3:59 PM EST
Pre-market
Day range
390
402.32999
Previous close
397.54999
Open
394.22000
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
391.50
6.05
1.52%

Statistics

Valuation metrics
Market cap
51.72B
Enterprise value
52.57B
Trailing P/E (ttm)
1.22K
Forward P/E
36.90
PEG ratio
-3.83
Price/Sales (ttm)
16.11
Price/Book (mrq)
220.56
Enterprise Value/Revenue
16.38
Enterprise Value/EBITDA
163.76
Overview
Shares outstanding
131.79M
Float
130.25M
Shares short
3.96M
% Held by insiders
1.48%
% Held by institutions
100.24%
Average volume (10 days)
1.35M
Average volume (90 days)
1.10M
Price summary
52-Week low
205.87
52-Week high
495.55
52-Week change
37.02 18.0%
Beta
0.30
50-Day moving average
453.86
200-Day moving average
361.09
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
1.36%
Operating margin
29.46%
Operational effectiveness
Return on assets
3.65%
Return on equity
32.72%
Income statement
Revenue (ttm)
3.21B
Revenue per share (ttm)
24.65
Quarterly revenue growth (yoy)
149.30%
Gross profit (ttm)
2.69B
EBITDA
321.02M
Net income to common (ttm)
43.57M
Diluted EPS (ttm)
0.32
Quarterly earnings growth (yoy)
149.35%
Balance sheet
Total cash (mrq)
2.72B
Total cash per share (mrq)
20.62
Total debt (mrq)
2.77B
Total Debt/Equity (mrq)
1.19K
Current ratio (mrq)
254.10%
Book value per share (mrq)
1.78
Cash flow
Cash flow statement
265.86M
Levered free cash flow (LFCF)
98.12M
Access /statistics data via our API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 5 hours 16 minutes

04:13
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).